Urenco Finance N.V. Publication of Final Terms (5279O)

TIDM44ZP

RNS Number : 5279O

Urenco Finance N.V.

10 June 2022

URENCO FINANCE N.V.

[10] June 2022

Publication of Final Terms

The following Final Terms are available for viewing:

Final Terms dated 9 June 2022 in respect of an issue of EUR500,000,000 3.250 per cent. Notes due 2032 (the Notes).

The Notes are issued under the EUR3,000,000,000 Euro Medium Term Note Programme established by Urenco Finance N.V. as Issuer and unconditionally and irrevocably guaranteed on a joint and several basis by Urenco Limited, Urenco UK Limited, Urenco Nederland B.V., Urenco Deutschland GmbH and Louisiana Energy Services, LLC.

The Final Terms in respect of the Notes must be read in conjunction with the Base Prospectus dated 27 May 2022 (the Base Prospectus). Full information on Urenco Finance N.V., and in respect of the offer of the Notes, is only available on the basis of the combination of the Base Prospectus and the Final Terms in respect of the Notes.

To view the Final Terms in respect of the Notes, please paste the URL below into the address bar of your browser.

https://www.urenco.com/cdn/uploads/supporting-files/Project_Chester_-_Final_Terms_(signed)_-_Conformed_Copy(259691706.1)_.pdf

A copy of the Final Terms will be submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

For further information, please contact:

Urenco Limited

Urenco Court

Sefton Park

Bells Hill

Stoke Poges

Bucks SL2 4JS

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Final Terms in respect of the Notes (when read together with the information in the Base Prospectus) may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms and Base Prospectus is not addressed. Prior to relying on the information contained in the Final Terms and the Base Prospectus you must ascertain whether or not you are part of the intended addressees of the information contained therein.

In particular, the Base Prospectus and the Final Terms in respect of the Notes do not constitute an offer of securities for sale in the United States. The Notes have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended, (the Securities Act) or under any relevant securities laws of any state of the United States of America and may not be offered or sold to U.S. persons or to persons within the United States of America except in certain transactions exempt from, or not subject to, the registration requirements of the Securities Act.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

PFTFLFVSRFIILIF

(END) Dow Jones Newswires

June 10, 2022 10:35 ET (14:35 GMT)